Retina Consultants of Texas - Katy

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Phase 3 Study of Intravitreal 4D-150 in Adults With Diabetic Macular Edema (DME) (4D-150-C005)	eye disorder	Recruiting	Phase 3	2026-10-09	NCT07867080
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio	Geographic Atrophy Secondary to Age-related Macular Degeneration	Recruiting	Phase 2	2026-06-24	NCT07215390
A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy	Geographic Atrophy, age-related macular degeneration, eye disorder, macular degeneration, retinal degeneration, retinal disorder	Active, not recruiting	Phase 2	2026-05-14	NCT06722157
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration	Neovascular Age-Related Macular Degeneration	Active, not recruiting	Phase 3	2025-04-18	NCT06223958

Clinical trials